Dominique Bédard

The Small Molecule GMX1778 Is a Potent Inhibitor of NAD ⁺ Biosynthesis: Strategy for Enhanced Therapy in Nicotinic Acid Phosphoribosyltransferase 1-Deficient Tumors

Mark H. Watson, Anne Roulston, Laurent Bélec et al. · Molecular and Cellular Biology · 2009 · 219 citations · Full text

Medicine, Oncology, Pharmacology +15

Probabilistic Multiple-Bias Modeling Applied to the Canadian Data From the Interphone Study of Mobile Phone Use and Risk of Glioma, Meningioma, Acoustic Neuroma, and Parotid Gland Tumors

Franco Momoli, Jack Siemiatycki, Mary L. McBride et al. · American Journal of Epidemiology · 2017 · 67 citations · Full text

Public Health, Biostatistics, Oncology +17

Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777

Pierre Beauparlant, Dominique Bédard, Cynthia Bernier et al. · Anti-Cancer Drugs · 2009 · 60 citations

Medicine, Pharmacokinetics, Pharmacology +14

The highly selective 5-HT2A antagonist EMD-281,014 reduces dyskinesia and psychosis in the l-DOPA-treated parkinsonian marmoset

Adjia Hamadjida, Stephen G. Nuara, Dominique Bédard et al. · Neuropharmacology · 2018 · 44 citations

Medicine, Neuroscience, Pharmacology +12

Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism

Imane Frouni, Adjia Hamadjida, Cynthia Kwan et al. · Neuropharmacology · 2019 · 40 citations

Life Sciences, Neuroscience, Pharmacology +14